Advertisement
News
Advertisement

Haemonetics completes acquisition of Pall line

Thu, 08/02/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

Braintree-based Haemonetics (NYSE: HAE), a blood management company, announced that it has completed the previously-announced acquisition of the blood collection, filtration and processing product lines of Pall Corp. for $550 million, and also reported its first quarter 2013 results.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading